Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

CUSIP: 75383L102

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
+24,647
SEC-reported price per share
$17.74
Number of holders
69
Value change
-$29,671
Number of buys
33
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
47,942,939

Security key

75383L102

Report period

Q4 2024

Institutions

69

Top holders

10

Ownership snapshot

Top reported holders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARCH Venture Partners XII...
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
3/4/5 13F Highest disclosed value: $112,362,864 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $112.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
ARCH Venture Partners XII, LLC $37.21M
FMR LLC $112.36M
ARCH Venture Management, LLC $76.36M
Cormorant Asset Management, LP $60.23M
Capital International Investors $53.3M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARCH Venture Partners XII, LLC
3/4/5
10%+ Owner
—
denominator unverified
$37,212,805
3,728,738 shares
— 10 Jun 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$112,362,864
5,486,468 shares
— 30 Sep 2024
ARCH Venture Management, LLC
13F
Company
13F
—
denominator unverified
$76,364,554
3,728,738 shares
— 30 Sep 2024
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$60,230,062
2,940,921 shares
— 30 Sep 2024
Capital International Investors
13F
Company
13F
—
denominator unverified
$53,299,794
2,602,529 shares
— 30 Sep 2024
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$51,160,084
2,498,051 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
69
Shares
36,577,539
Rows available
69
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
55
Q4 2024 holders
69
Holder diff
14
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .